The technology that guarantees the best absorption of Iron.
Find out moreWelcome to the reserved area of SiderAL®
This area has been set up specifically for doctors, researchers and healthcare professionals seeking detailed information and scientific studies regarding the use of Sucrosomial® Iron and its effects in a variety of clinical sectors.
Iron deficiency is evidently a common issue in numerous medical disciplines, also differing greatly from one another, and still today is the first cause of anaemia, as well as being ranked as the most widespread nutritional deficiency worldwide.
By subscribing to the reserved area of SiderAL® you will have access to a free and constantly updated collection of national and international clinical studies, which highlight the efficacy and tolerability of Sucrosomial® Iron in the treatment of sideropenia in the following clinical sectors:
Iron deficiency is evidently a common issue in numerous medical disciplines, also differing greatly from one another, and still today is the first cause of anaemia, as well as being ranked as the most widespread nutritional deficiency worldwide.
By subscribing to the reserved area of SiderAL® you will have access to a free and constantly updated collection of national and international clinical studies, which highlight the efficacy and tolerability of Sucrosomial® Iron in the treatment of sideropenia in the following clinical sectors:
GENERAL RESEARCH
This collection of in vivo and in vitro clinical studies demonstrate the efficacy of SiderAL® on animal, biological tissue and cell culture models
CARDIOLOGY
The studies in this section focus on raising haemoglobin levels and improving post-operative progress in subjects suffering from various types of cardiac pathologies.
HEMATOLOGY
This section collects studies concerning the management of iron deficiency caused by blood disorders, such as myelodysplastic syndromes
GASTROENTEROLOGY
A collection of scientific evidence relating to subjects suffering from gastrointestinal disorders, including inflammatory bowel disease (IBD), obesity and coeliac disease.
GERIATRICS
Studies in this section focus on the elderly population suffering from iron deficiency and sideropenic anaemia.
GYNAECOLOGY
This section contains studies and research on the haemoglobin profile of pregnant women and the foetus; the studies also describe the benefits of an optimal iron supplement during pregnancy, such as achieving the correct weight of the baby at birth.
INTERNAL MEDICINE
This section provides a collection of studies regarding various clinical conditions, such as inflammatory states in athletes and multi-factor anaemia
TRANSFUSIONAL MEDICINE
The research and studies in this section focus on subjects requiring blood transfusions, and in general, the efficacy of iron supplements as part of PBM (Patient Blood Management) protocols.
NEPHROLOGY
This section is dedicated to studies concerning kidney disorders, which cause alterations in the main blood parameters, as occurs in patients with chronic renal insufficiency (CRI).
ONCOLOGY
Studies in this section highlight the status of iron deficiency in cancer patients, with the main objective of improving blood profiles and general quality of life
PAEDIATRICS
The collection of studies in this section focus on paediatric patients, starting from the first year of life through to adolescence.
Subscription to the reserved area and its free contents is reserved to healthcare professionals. The subscription request must be validated and confirmed before access is granted to the reserved area and scientific studies.
PharmaNutra Spa
Registered Office Via Campodavela, 1 56122 Pisa
Tel. +39 050 7846500
Fax +39 050 7846524
C.F. / P.Iva / Reg. Impr. 01679440501
Cap.Soc. € 1.123.097,70
I.V. | REA 146259
pharmanutra.it
Copyright © - Pharmanutra SpA. All Rights Reserved.